CustomVue offers good results in mixed astigmatism

Article

Excellent visual outcomes can be achieved in subjects with mixed astigmatism when using the VISX wavefront platform's CustomVue iris registration system (AMO).

Excellent visual outcomes can be achieved in subjects with mixed astigmatism when using the VISX wavefront platform's CustomVue iris registration system (AMO), according to Baha Toygar and co-workers from the Dunya Eye Hospital, Istanbul, Turkey.

Sixteen eyes with mixed astigmatism were enrolled into the prospective study in which all LASIK procedures were performed by the same surgeon.

Three months following surgery, mean astigmatism had reduced from -3.14±1.06 D to -0.33±0.44 D. The majority of eyes (81%) had less than -0.50 D residual astigmatism and 87.5% had less than -1.0 D. Mean uncorrected and best corrected visual acuity (UCVA & BCVA) improved from 0.24±0.13 to 0.79±0.27 and from 0.84±0.20 to 0.95±0.11, respectively.

Overall, these results demonstrate that the VISX wavefront platform's CustomVue iris registration system can offer excellent visual outcomes for subjects with mixed astigmatism.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.